Asian Journal of Psychiatry
Volume 2, Issue 1 , Pages 29-36 , March 2009

An analysis of the high psychotropic off-label use in psychiatric disorders: The majority of psychiatric diagnoses have no approved drug

  • Kavi K. Devulapalli

      Affiliations

    • Case Western Reserve University, Cleveland, OH 44106, United States
    • ,
  • Henry A. Nasrallah

      Affiliations

    • University of Cincinnati College of Medicine, 260 Stetson Street, Suite 3224, Cincinnati, OH 45219, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 513 558 4615.

Received 27 August 2008 ,Accepted 7 January 2009.

References 

  1. Baethge C. Long-term treatment of schizoaffective disorder: review and recommendations. Pharmacopsychiatry. 2003;36:45–56
  2. Blazinski, C., 2002. Drugs intended for the treatment of epilepsy and schizophrenia are often used for other diseases. Decision Resources 21, 2002.
  3. Buckley PF. Broad therapeutic uses of atypical antipsychotic medications. Biol. Psychiatry. 2001;50:912–924
  4. Challman TD, Lipsky JJ. Methylphenidate: its pharmacology and uses. Mayo Clinic Proc. 2000;75:711–721
  5. Chawla H, Diwana N, Joshi K. Emerging trends in world pharmaceutical market: a review. Pharmatech Business Briefing. North American Pharmacotherapy; 2004;pp. 22–24
  6. Chen H, Reeves JH, Fincham JE, Kennedy WK, Dorfman JH, Martin BC. Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001. J. Clin. Psychiatry. 2006;67:972–982
  7. Findling RL, Steiner H, Weller EB. Use of antipsychotics in children and adolescents. J. Clin. Psychiatry. 2005;66(Suppl. 7):29–40
  8. Fountoulakis KN, Nimatoudis I, Iacovides A, Kaprinis G. Off-label indications for atypical antipsychotics: a systematic review. Ann. Gen. Hospital Psychiatry. 2004;3:4
  9. Fuller, MA., Sajatovic, M., 2005. Alphabetical listing of drugs. In: Fuller, MA., Sajatovic, M. (Eds.), Psychotropic Drug Information Handbook. Lexi-Comp, Hudson, pp. 19–570.
  10. Gillies D, Beck A, McCloud A, Rathbone J, Gillies D. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Cochrane Database Syst. Rev. (Online). 2005;CD003079
  11. Glick ID, Murray SR, Vasudevan P, Marder SR, Hu RJ. Treatment with atypical antipsychotics: new indications and new populations. J. Psychiatr. Res. 2001;35:187–191
  12. Goldberg JF, Citrome L. Latest therapies for bipolar disorder. Looking beyond lithium. Postgraduate Med. 2005;117:25-26, 29-32, 35-26
  13. Haw C, Stubbs J. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness. J. Intellect. Disabil. Res. 2005;49:858–864
  14. Hosak L, Libiger J. Antiepileptic drugs in schizophrenia: a review. Eur. Psychiatry. 2002;17:371–378
  15. Insel TR, Hamilton JA, Guttmacher LB, Murphy DL. D-amphetamine in obsessive-compulsive disorder. Psychopharmacology. 1983;80:231–235
  16. Kolevzon A, Mathewson KA, Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J. Clin. Psychiatry. 2006;67:407–414
  17. Kramer SI, McCall WV. Off-label prescribing: 7 steps for safer nad more effective treatment. Curr. Psychiatry. 2006;5:14–28
  18. Kripke C. Drug treatments for patients with dysthymia. Am. Family Physician. 2004;70:1269–1270
  19. Lindamood W. Thorazine. Chem. Eng. News. 2003;83:126
  20. Markovitz PJ. Recent trends in the pharmacotherapy of personality disorders. J. Personality Disorders. 2004;18:90–101
  21. Mason PW, Krawiecki N, Meacham LR. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch. Pediatr. Adolesc. Med. 2002;156:887–892
  22. Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst. Rev. (Online). 2005;CD002919
  23. O’Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. J. Family Pract. 1999;48:980–990
  24. Pederson KJ, Roerig JL, Mitchell JE. Towards the pharmacotherapy of eating disorders. Exp. Opin. Pharmacother. 2003;4:1659–1678
  25. Potenza MN, McDougle CJ. Potential of atypical antipsychotics in the treatment of nonpsychotic disorders. CNS Drugs. 1998;9:213–232
  26. Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch. Internal Med. 2006;166:1021–1026
  27. Reddy S, Patt RB. The benzodiazepines as adjuvant analgesics. J. Pain Sympt. Manage. 1994;9:510–514
  28. Rosenberg JM, Salzman C. Update: new uses for lithium and anticonvulsants. CNS Spectrums. 2007;12:831–841
  29. Schatzberg AF, DeBattista C. Psychotropic dosing and monitoring guidelines. Primary Psychiatry. 2004;11:62–78
  30. Soares KV, McGrath JJ, Deeks JJ. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst. Rev. (Online). 2001;CD000203
  31. Tonda ME, Guthrie SK. Treatment of acute neuroleptic-induced movement disorders. Pharmacotherapy. 1994;14:543–560
  32. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2003;27:85–102
  33. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst. Rev. (Online). 2005;CD001133
  34. Wills L, Garcia J. Parasomnias: epidemiology and management. CNS Drugs. 2002;16:803–810
  35. Witek MW, Rojas V, Alonso C, Minami H, Silva RR. Review of benzodiazepine use in children and adolescents. Psychiatr. Q. 2005;76:283–296
  36. Wolfsperger M, Greil W, Rossler W, Grohmann R. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J. Affective Disord. 2007;99:9–17
  37. Zullino DF, Khazaal Y, Hattenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today (Barc). 2004;40:603–619

PII: S1876-2018(09)00005-7

doi: 10.1016/j.ajp.2009.01.005

Asian Journal of Psychiatry
Volume 2, Issue 1 , Pages 29-36 , March 2009

Article Tools

* Image Usage & Resolution